Факторы роста, их рецепторы и нижележащие сигнальные белки: от эксперимента к клинике
ЕС Герштейн, НЕ Кушлинский - Успехи молекулярной онкологии, 2014 - cyberleninka.ru
В обзоре представлены основополагающие данные современной литературы и
результаты собственных многолетних исследований роли ауто/паракринных факторов …
результаты собственных многолетних исследований роли ауто/паракринных факторов …
Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab
M Yamazaki, Y Yamashita, N Kubo… - Oncology …, 2012 - spandidos-publications.com
The ERBB proteins are cell membrane tyrosine kinase receptors. Among these receptors,
ERBB1 (EGFR or HER1) and ERBB2 (HER2/Neu) have been reported to be the most …
ERBB1 (EGFR or HER1) and ERBB2 (HER2/Neu) have been reported to be the most …
Molecular imaging application of radioiodinated anti-EGFR human Fab to EGFR-overexpressing tumor xenografts
N Xu, G Cai, W Ye, X Wang, Y Li, P Zhao… - Anticancer …, 2009 - ar.iiarjournals.org
Background: Suitable diagnostics could identify patients who might benefit from targeted
therapies. Molecular imaging is a promising method estimating the expression of specific …
therapies. Molecular imaging is a promising method estimating the expression of specific …
Validating pharmacological disruption of protein–protein interactions by acceptor photobleaching FRET imaging
Proteins are the major targets of drug discovery and many of the new drugs are designed to
exert their effect by disrupting protein-protein interactions. Validation of the inhibition of …
exert their effect by disrupting protein-protein interactions. Validation of the inhibition of …
Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell …
S Sapski, N Beha, RE Kontermann, D Müller - Cancer Immunology …, 2020 - Springer
Target expression heterogeneity and the presence of an immunosuppressive
microenvironment can hamper severely the efficiency of immunotherapeutic approaches …
microenvironment can hamper severely the efficiency of immunotherapeutic approaches …
Pertuzumab increases 17-AAG-induced degradation of ErbB2, and this effect is further increased by combining pertuzumab with trastuzumab
JB Hughes, MS Rødland, M Hasmann, IH Madshus… - Pharmaceuticals, 2012 - mdpi.com
ErbB2 is an important oncogenic protein involved in carcinogenesis of, among others,
breast, gastric, and ovarian carcinoma. Over-expression of ErbB2 is found in almost 20% of …
breast, gastric, and ovarian carcinoma. Over-expression of ErbB2 is found in almost 20% of …
The in vitro influences of epidermal growth factor and heregulin-β1 on the efficacy of trastuzumab used in Her-2 positive breast adenocarcinoma
T Hurrell, K Outhoff - Cancer cell international, 2013 - Springer
Background Human epidermal growth factor receptor-2 (Her-2) is over expressed in
approximately 25-30% of all primary breast tumors resulting in a distinctive breast cancer …
approximately 25-30% of all primary breast tumors resulting in a distinctive breast cancer …
Development of an affinity-matured humanized anti-epidermal growth factor receptor antibody for cancer immunotherapy
T Nakanishi, T Maru, K Tahara… - … , Design & Selection, 2013 - academic.oup.com
We showed previously that humanization of 528, a murine anti-epidermal growth factor
receptor (EGFR) antibody, causes reduced affinity for its target. Here, to improve the affinity …
receptor (EGFR) antibody, causes reduced affinity for its target. Here, to improve the affinity …
Resistance to cetuximab in EGFR-overexpressing esophageal squamous cell carcinoma xenografts due to FGFR2 amplification and overexpression
Y Zhang, T Pan, X Zhong, C Cheng - Journal of pharmacological …, 2014 - jstage.jst.go.jp
Esophageal carcinoma is one of the most virulent malignant diseases and a major cause of
cancer-related deaths worldwide. Despite improvements in surgical techniques and …
cancer-related deaths worldwide. Despite improvements in surgical techniques and …
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy
C De Giovanni, L Landuzzi, A Palladini, G Nicoletti… - Cells, 2021 - mdpi.com
Rhabdomyosarcomas (RMS) are tumors of the skeletal muscle lineage. Two main features
allow for distinction between subtypes: morphology and presence/absence of a …
allow for distinction between subtypes: morphology and presence/absence of a …